A highly-recognized Canadian life sciences leader with broad international experience, Karimah Es Sabar has had a successful career spanning the global biopharmaceutical industry, start-ups, not-for-profit organizations and venture investment. Over the course of her career, she has raised over $1.5B for various private and public global biosciences enterprises. In 2016, Ms. Es Sabar accepted the position of CEO & Partner at Quark Venture LP to lead and build their health sciences enterprise. Through a joint venture with GF Securities the Global Health Sciences [GHS] Fund was established, which invests globally in health bioscience companies with disruptive platforms and technologies.
She served as Senior Vice-President, Business and Strategic Affairs of The Centre for Drug Research and Development, Canada’s national drug development and commercialization centre. Currently, she is the chair of Health Biosciences Economic Strategy Table.
